1Parkin DM. Global cancer statistics in the year 2000[J]. Lancet Oncol, 2001,2: 533- 543
2Okuda K,Obata H, Nakajima Y, et al . Prognosis in primary hepatocellular carcinoma [J]. Hepatology,1984,4:3S-6S
3Primack A, Vogel CL, Kyalwazi SK, et al . A staging system of hepatocellular carcinoma: Prognostic factors in Ugandan patients [J]. Cancer, 1975, 35:1357-1364
4Okuda K, Ohtsuki T, Obata H, et al . Natural history of hepatocellular carcinoma and prognosis in relation to treatment[J]. Cancer, 1985,56: 918 - 928
5Levy I, Sherman M. Staging of hepatocellular carcinoma: assessment of the CLIP, Okuda, and ChildPugh staging systems in a cohortof 257 patients in Toronto[J]. Gut, 2002,50: 881 - 885
6Kudo M, Chung H, Osaki Y. Prognostic staging system for hepatocellular carcinoma (CLIP score): its value and limitations, and a proposal for a new staging system, the Japan Integrated Staging Score (JISscore) [J]. J Gastroenterol, 2003,38: 207- 215
7Llovet JM, Bru C, Bruix J. Prognosis of hepatocellular carcinoma: the BCLC staging classification[J].Semin Liver Dis, 1999,19(3): 329- 338
8The Cancer of the Liver Italian Program (CLIP) Investigators. A new prognostic system for hepatocellular carcinoma: a retrospective study of 435 patients[J]. Hepatology, 1998,28: 751- 755
9The Cancer of the Liver Italian Program (CLIP) Investigators. Prospective Validation of the CLIPScore: A New Prognostic System for Patients With Cirrhosis and Hepatocellular Carcinoma[J]. Hepatology,2000,31:840-845
10Farinati F, Rinaldi M, Gianni S, et al . How should patients with hepatocellular carcinoma be staged?Validation of a new prognostic system[J]. Cancer,2000,89:2266-2273
5Hara N, Kasailara T, Kawasaki T, et al. Reverse transcription- polymerase chain raetion detection of proslale-specific antigen, prqstate-specific membrane antigen, and proslale slem cell antigen in one milliliter of peripheral blood: value flJr the staging of prostate cancer[ J]. Clin Cancer Res,2002,8(6) :1794-1799.
6Feitelson M A. Hepatitis B x antigen and p53 in the developm:nt of hepatocellular t:arcinoma [ J ]. J Hepatobiliary Pancreat Surg, 1998, 5 ( 4 ) : 367-374.
7Bedard L L, Alessi M, I)avey S,et al. Susceptibility Io af]atoxin BI- induced carcinogenesis correlates witll tissue-specific differences in DNA repair activily in mouse and in rat[ J ]. Cancer Rcs, 2005,65 (4) :1265-1270.
8lizuka N, Oka' M, Yamada-Okabe H, et al. Comparison of gene expression profiles between hepatitis B virus- and hepatitis C virus- infected hepatoeellular carinmla by oligonueleotidc microarray dda on the basis of a supervised learning method[ J]. Cancer Res, 2002, 62(14) :3939- 3944.
9Honda M, Kaneko S, Kawai H, et al. Differential gene cxpu'cssion between chronic hepatitis B and C hepatic lesion [ J ]. Gastroenterology, 2001 , 120 ( 4 ) : 955 -966.
10Gomaa A 1, Khan S A, l,cen E L, et al Diagnosis of hepatocdlular carcinoma [ J ]. World J Gasmenterol, 2009, 1 5 ( 11 ) : 1301 -1 314.
